Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New antithrombotic agents described by Pfizer

Dec. 23, 1996

Schering-Plough claims novel use for Flt3 ligand

Dec. 23, 1996

Takeda claims new treatments for pancreatitis

Dec. 23, 1996

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

Mercian discovers other anthracycline antineoplastic agents

Dec. 20, 1996

Fujisawa synthesizes novel bone resorption inhibitors

Dec. 20, 1996

Grelan, Fournier collaborate on ACAT inhibitors

Dec. 20, 1996

Tetracycline antibacterial agents under study at Pfizer

Dec. 20, 1996

Schering-Plough reveals new NK antagonists

Dec. 20, 1996

Dual NEP/ACE inhibitors claimed by Eisai

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...